172 related articles for article (PubMed ID: 37526864)
21. Raised keratinocyte growth factor-1 expression in oral submucous fibrosis in vivo and upregulated by arecoline in human buccal mucosal fibroblasts in vitro.
Tsai CH; Yang SF; Chen YJ; Chou MY; Chang YC
J Oral Pathol Med; 2005 Feb; 34(2):100-5. PubMed ID: 15641989
[TBL] [Abstract][Full Text] [Related]
22. Glabridin inhibits the activation of myofibroblasts in human fibrotic buccal mucosal fibroblasts through TGF-β/smad signaling.
Lee PH; Chu PM; Hsieh PL; Yang HW; Chueh PJ; Huang YF; Liao YW; Yu CC
Environ Toxicol; 2018 Feb; 33(2):248-255. PubMed ID: 29119715
[TBL] [Abstract][Full Text] [Related]
23. Paeonol inhibits profibrotic signaling and HOTAIR expression in fibrotic buccal mucosal fibroblasts.
Ho DC; Chen SH; Fang CY; Hsieh CW; Hsieh PL; Liao YW; Yu CC; Tsai LL
J Formos Med Assoc; 2022 May; 121(5):930-935. PubMed ID: 34696937
[TBL] [Abstract][Full Text] [Related]
24. Arecoline Enhances Phosphodiesterase 4A Activity to Promote Transforming Growth Factor-β-Induced Buccal Mucosal Fibroblast Activation via cAMP-Epac1 Signaling Pathway.
Zhang B; Gao L; Shao C; Deng M; Chen L
Front Pharmacol; 2021; 12():722040. PubMed ID: 34819854
[TBL] [Abstract][Full Text] [Related]
25. Aberrant SSEA-4 upregulation mediates myofibroblast activity to promote pre-cancerous oral submucous fibrosis.
Yu CC; Yu CH; Chang YC
Sci Rep; 2016 Nov; 6():37004. PubMed ID: 27845370
[TBL] [Abstract][Full Text] [Related]
26. Elevation of S100A4 expression in buccal mucosal fibroblasts by arecoline: involvement in the pathogenesis of oral submucous fibrosis.
Yu CC; Tsai CH; Hsu HI; Chang YC
PLoS One; 2013; 8(1):e55122. PubMed ID: 23383075
[TBL] [Abstract][Full Text] [Related]
27. Curcumin relieves arecoline-induced oral submucous fibrosis via inhibiting the LTBP2/NF-κB axis.
Zhang L; Tan J; Liu Y; Luo M
Oral Dis; 2024 May; 30(4):2314-2324. PubMed ID: 37382472
[TBL] [Abstract][Full Text] [Related]
28. miR-203 inhibits arecoline-induced epithelial-mesenchymal transition by regulating secreted frizzled-related protein 4 and transmembrane-4 L six family member 1 in oral submucous fibrosis.
Zheng L; Jian X; Guo F; Li N; Jiang C; Yin P; Min AJ; Huang L
Oncol Rep; 2015 Jun; 33(6):2753-60. PubMed ID: 25872484
[TBL] [Abstract][Full Text] [Related]
29. Elevated transglutaminase-2 expression mediates fibrosis in areca quid chewing-associated oral submucocal fibrosis via reactive oxygen species generation.
Lee SS; Chen YJ; Tsai CH; Huang FM; Chang YC
Clin Oral Investig; 2016 Jun; 20(5):1029-34. PubMed ID: 26336810
[TBL] [Abstract][Full Text] [Related]
30. Arecoline activates latent transforming growth factor β1 via mitochondrial reactive oxygen species in buccal fibroblasts: Suppression by epigallocatechin-3-gallate.
Hsieh YP; Wu KJ; Chen HM; Deng YT
J Formos Med Assoc; 2018 Jun; 117(6):527-534. PubMed ID: 28720506
[TBL] [Abstract][Full Text] [Related]
31. circMTO1/miR-30c-5p/SOCS3 axis alleviates oral submucous fibrosis through inhibiting fibroblast-myofibroblast transition.
Bin X; Cheng JY; Deng ZY; Li B; Xu XH; Liu OS; Tang Z
J Oral Pathol Med; 2024 May; ():. PubMed ID: 38802299
[TBL] [Abstract][Full Text] [Related]
32. Hypoxic regulation of plasminogen activator inhibitor-1 expression in human buccal mucosa fibroblasts stimulated with arecoline.
Tsai CH; Lee SS; Chang YC
J Oral Pathol Med; 2015 Oct; 44(9):669-73. PubMed ID: 25367145
[TBL] [Abstract][Full Text] [Related]
33. DNA methyltransferase 3A induces the occurrence of oral submucous fibrosis by promoting the methylation of the von Hippel-Lindau.
Kuang H; Yang L; Li Z; Wang J; Zheng K; Mei J; Sun H; Huang Y; Yang C; Luo W
Oral Dis; 2024 May; 30(4):2325-2336. PubMed ID: 37743610
[TBL] [Abstract][Full Text] [Related]
34. STRO-1 confers myofibroblast transdifferentiation in fibroblasts derived from oral submucous fibrosis.
Yu CC; Liao YW; Yu CH; Chang YC
J Oral Pathol Med; 2018 Mar; 47(3):299-305. PubMed ID: 29210111
[TBL] [Abstract][Full Text] [Related]
35. Transforming growth factor β1 signaling coincides with epithelial-mesenchymal transition and fibroblast-to-myofibroblast transdifferentiation in the development of adenomyosis in mice.
Shen M; Liu X; Zhang H; Guo SW
Hum Reprod; 2016 Feb; 31(2):355-69. PubMed ID: 26689216
[TBL] [Abstract][Full Text] [Related]
36. Honokiol inhibits arecoline-induced oral fibrogenesis through transforming growth factor-β/Smad2/3 signaling inhibition.
Chen PY; Ho DC; Liao YW; Hsieh PL; Lu KH; Tsai LL; Su SH; Yu CC
J Formos Med Assoc; 2021 Nov; 120(11):1988-1993. PubMed ID: 33980461
[TBL] [Abstract][Full Text] [Related]
37. Targeting lncRNA H19/miR-29b/COL1A1 Axis Impedes Myofibroblast Activities of Precancerous Oral Submucous Fibrosis.
Yu CC; Liao YW; Hsieh PL; Chang YC
Int J Mol Sci; 2021 Feb; 22(4):. PubMed ID: 33672311
[TBL] [Abstract][Full Text] [Related]
38. [Effects of Notch-1/Twist-1 axis in the process of epithelial-mesenchymal transition of type II alveolar epithelial cell and its mechanism].
Tang J; Ke J; Fu Y; He XW; Li XW
Zhongguo Ying Yong Sheng Li Xue Za Zhi; 2021 Nov; 37(6):577-583. PubMed ID: 34821087
[No Abstract] [Full Text] [Related]
39. Mechanism of adipose tissue-derived stromal cell-extracellular vesicles in treating oral submucous fibrosis by blocking the TGF-β1/Smad3 pathway via the miR-760-3p/IGF1R axis.
Wang F; Jiang L; Liu P; Jiang Y
Biomol Biomed; 2023 Dec; ():. PubMed ID: 38059910
[TBL] [Abstract][Full Text] [Related]
40. A biomaterial-based therapy using a sodium hyaluronate/bioglass composite hydrogel for the treatment of oral submucous fibrosis.
Guo ZX; Zhang Z; Yan JF; Xu HQ; Wang SY; Ye T; Han XX; Wang WR; Wang Y; Gao JL; Niu LN; Chang J; Jiao K
Acta Biomater; 2023 Feb; 157():639-654. PubMed ID: 36509401
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]